Genentech Inc (bought by RHHBY) (DNA)
With more than 700 scientists studying everything from neurology to asthma, this Bay Area company is one of the biggest players in the biotechnology industry. Some of the drugs it developed are include Activase, synthetic insulin, and Lucentis.
i have been watching you and i haven't seen any gain or loss of your salary.
So, is no one else bummed out by the Roche takeover? I admit that the only reason I'm bummed is because I really liked Genentech as a company, and I know nothing about Roche...anyone have some insight for me?
Roche is tough, aggressive, VERY GERMAN...and has always done well. its a good fit....The Roche Germans will make Genentech perform well and make a profit. Genentech has lots of great ideas, but they run by a bunch of genius scientists who don't know much about finance or profits. Genentech has made billions on just its name and has not brought anything much to the market. But, the seeds are there for Genentech to do extremely well...with Roche in the driver's seat.- over 2 years ago
"On March 26, 2009, Roche completed its acquisition of Genentech pursuant to a short-form merger in which Genentech became a wholly-owned member of the Roche Group. Roche had announced earlier in the day the successful completion of its tender offer, which expired on Wednesday, March 25. In connection with the merger, all remaining public shareholders will, subject to appraisal rights, receive $95.00 per share for their shares. Genentech's common stock will no longer be traded on the New York Stock Exchange after Thursday, March 26."
cdd3683 thinks if Genentech Inc were a Ben & Jerry's flavor, it would be Phish Food.
gabereal thinks if Genentech Inc were a classic videogame character, it would be Sonic the Hedgehog.
Pratima thinks if Genentech Inc were a Sweet Tart, it would be cherry.
Events
-
May312012Dalradian Resources Inc. Presents at World Mining Investment Congress 2012, May-29-2012 through May-31-2012
-
May312012Dalradian Resources Inc. Presents at Africa Mining Congress 2012, May-29-2012 through May-31-2012
-
June252012Dalradian Resources Inc., Annual General Meeting, Jun 25, 2012
-
August112012Dalradian Resources Inc. expected to report Q2 2012 results on August 11, 2012. This event was calculated by Capital IQ (Created on May 17, 2012).
-
September 92012Dalradian Resources Inc. Presents at Denver Gold Forum 2012, Sep-09-2012
Members who own this company also own
Current price per share
Today's gain: $0.00 (0.00%)
